Risk of peritoneal dissemination in stomach cancer

1. IACR. World Cancer Report 2014. Stewart BW, Wild CP, editors. Lyon: World Health Organization; February 2014.Search in Google Scholar

2. Lauren P. The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called Intestinal-Type Carcinoma. An Attempt at a Histo-Clinical Classification. Acta Pathol Microbiol Scand. 1965;64:31-49.10.1111/apm.1965.64.1.31Open DOISearch in Google Scholar

3. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;1(8336):1273-5.Search in Google Scholar

4. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10(8):789-99.10.1038/nm1087Search in Google Scholar

5. Setia N, Agoston AT, Han HS, Mullen JT, Duda DG, Clark JW, et al. A protein and mRNA expression-based classification of gastric cancer. Mod Pathol. 2016;29(7):772-84.10.1038/modpathol.2016.55Search in Google Scholar

6. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374(9688):477-90.10.1016/S0140-6736(09)60617-6Search in Google Scholar

7. Kanda M, Kodera Y. Molecular mechanisms of peritoneal dissemination in gastric cancer. World J Gastroenterol. 2016;22(30):6829-40.10.3748/wjg.v22.i30.6829Search in Google Scholar

8. Liu J, Geng X, Li Y. Milky spots: omental functional units and hotbeds for peritoneal cancer metastasis. Tumour Biol. 2016;37(5):5715-26.10.1007/s13277-016-4887-3Search in Google Scholar

9. Zhang LL, Liu J, Lei S, Zhang J, Zhou W, Yu HG. PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression. Cell Signal. 2014;26(5):1011-20.10.1016/j.cellsig.2014.01.025Open DOISearch in Google Scholar

10. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687-97.10.1016/S0140-6736(10)61121-XSearch in Google Scholar

11. Chen CN, Chang CC, Lai HS, Jeng YM, Chen CI, Chang KJ, et al. Connective tissue growth factor inhibits gastric cancer peritoneal metastasis by blocking integrin alpha3beta1-dependent adhesion. Gastric Cancer. 2015;18(3):504-15.10.1007/s10120-014-0400-024985492Search in Google Scholar

12. Yonemura Y, Endou Y, Fujita H, Fushida S, Bandou E, Taniguchi K, et al. Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer. Gastric Cancer. 2000;3(2):63-70.10.1007/PL0001169811984713Open DOISearch in Google Scholar

13. Javle M, Smyth EC, Chau I. Ramucirumab: successfully targeting angiogenesis in gastric cancer. Clin Cancer Res. 2014;20(23):5875-81.10.1158/1078-0432.CCR-14-1071425286925281695Search in Google Scholar

14. Sugarbaker TA CD, Koslowe P, Sugarbaker PH. Patterns of spread of recurrent intraabdominal sarcoma. PH S, editor. Boston: Kluwer Academic; 1996.10.1007/978-1-4613-1247-5_58849944Search in Google Scholar

15. Zhang J, Rector J, Lin JQ, Young JH, Sans M, Katta N, et al. Nondestructive tissue analysis for ex vivo and in vivo cancer diagnosis using a handheld mass spectrometry system. Sci Transl Med. 2017;9(406).10.1126/scitranslmed.aan3968583013628878011Search in Google Scholar